0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – GC Pharma

    GC Biopharma Corp (GC Biopharma), formerly known as GC Pharma, a subsidiary of Green Cross Holdings Corp, provides plasma protein therapeutics and vaccines. The company develops, manufactures, and markets a wide product portfolio comprising plasma derivatives including albumin, immunoglobulin, and antithrombin; vaccines for infectious diseases; prescription drugs for treating cardiovascular, respiratory, central nervous system (CNS), gastrointestinal and immunology diseases, musculoskeletal disorders, genetic disorders, metabolic disorders and hematological disorders; and Over-the-counter (OTC) drugs including anti-inflammatory drugs, anti-allergic products, and others. The...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Ascendis Pharma AS

    Ascendis Pharma AS (Ascendis Pharma) is a biopharmaceutical company that focuses on developing drugs for endocrinology and oncology indications. It is investigating TransCon hGH, a long-acting human growth hormone prodrug targeting GHD (growth hormone deficiency); TransCon PTH drug to treat hypoparathyroidism by restoring physiologic levels of PTH (parathyroid hormone); and TransCon CNP, a CNP (C-type natriuretic peptide) drug against achondroplasia (ACH). It is also evaluating TransCon TLR (toll-like receptor) 7/8 agonist, and TransCon IL-2 β/γ, an interleukin-2 variant that activates...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Zealand Pharma AS

    Zealand Pharma AS (Zealand) is a biotechnology company. It discovers, designs and develops peptide-based medicines that target specialty diseases. The company's product portfolio comprises glepaglutide which is a long-acting GLP-2 analog in development for the treatment of short bowel syndrome and dasiglucagon is used against type 1 diabetes and congenital hyperinsulinism. It also offers GLP1-GLU which is used against several cardio-metabolic diseases such as heart disease, ischemic stroke and liver diseases. Zealand conducts research and development and in-licensing programs. It...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Recro Pharma Inc

    Societal CDMO Inc (Societal CDMO), formerly Recro Pharma Inc, provides contract development and manufacturing organization (CDMO) services. The company harnesses formulation capabilities and proprietary delivery technologies for the development, manufacture, and commercialization of pharmaceutical products of its partners. The company manufactures products such as Ritalin LA, Verelan SR, Focalin XR, Verelan PM, Verapamil PM, Verapamil SR, Donnatal liquids and tablets with the commercial partners. The company’s commercial partners such as Teva, Novartis, Lannett, Advanz and Infectopharma. It also provides services...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – InnoCare Pharma Ltd

    InnoCare Pharma Ltd (InnoCare) is a biopharmaceutical company that discovers and develops novel treatments for cancer and autoimmune diseases. The company’s pipeline product portfolio includes ICP-022 a Bruton Tyrosine Kinase (BTK) inhibitor to treat B cell malignancies; ICP-105, an inhibitor for the treatment of hepatocellular carcinoma (HCC); ICP-192 a novel compound that targets gene abnormalities in solid tumor. It serves in the therapeutic areas of gastrointestinal cancer, liver cancer, lupus and rheumatoid arthritis. The company builds a fully integrated biopharmaceutical...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Hookipa Pharma Inc

    Hookipa Pharma Inc (Hookipa) is a clinical-stage biopharmaceutical company that develops novel class of immunotherapeutics against infectious diseases and cancers. Its pipeline products include HB-101, a prophylactic cytomegalovirus vaccine candidate; HB-202 and HB-201, immuno-oncology product candidates for the treatment of human papillomavirus-positive cancers; and HB-301, targeting prostate cancer. Hookipa’s proprietary arenavirus-based technologies, VaxWave, a replication-deficient viral vector, and TheraT, a replication-attenuated viral vector, are designed to induce antigen specific cytotoxic T cells and pathogen-neutralizing antibodies for prophylactic and therapeutic purposes...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – BridgeBio Pharma Inc

    BridgeBio Pharma Inc (BridgeBio) is a clinical-stage biotechnology company that develops novel medicines for genetic diseases. The company’s pipeline product portfolio includes precision cardiorenal drugs such as acoramidis, encaleret, BBP-711; mendelian disease drugs which include acoramidis, fosdenopterin, patidegib topical gel, low-dose infigratnib, BBP-589, BBP-551, BBP-418, BBP-681, BBP-671, among others; precision oncology drugs which include high-dose infigratinib, BBP-398, BBP-454, BBP-954. BridgeBio also carries out various phases of clinical trials such as pre-clinical, phase I, phase II studies. The company’s academic partners...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Aurobindo Pharma Ltd

    Aurobindo Pharma Ltd (Aurobindo) is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its product portfolio is spread across major therapeutic and product categories including antibiotics, anti-retroviral, systemic gastroenterological, central nervous system, cardiovascular, anti-allergies, anti-diabetics, other therapeutic areas. The company also produces novel proprietary biocatalysts, vitamins, minerals, dietary supplements, sports nutrition, functional foods, weight loss products and fermentation-based semi-synthetic products. Aurobindo operates manufacturing facilities in India, Brazil, Portugal and the US; and...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Albireo Pharma Inc

    Albireo Pharma Inc (Albireo), formerly Biodel Inc, It focuses on the development and commercialization of novel bile acid modulators for treatment of orphan pediatric liver diseases, gastrointestinal (GI) disorders and other diseases. Its pipeline products include odevixibat (A4250) intended for treatment of progressive familial intrahepatic cholestasis (PFIC), biliary atresia, alagille syndrome and other cholestaticc; A3384 for bile acid malabsorption; and elobixibat for nonalcoholic steatohepatitis (NASH). Elobixibat is approved in Japan for the treatment of chronic constipation. The company is investigating...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Lumos Pharma Inc

    Lumos Pharma Inc (Lumos Pharma), formerly NewLink Genetics Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of new therapies for the treatment of unmet medical needs of rare diseases. The company’s lead investigating candidate, LUM-201 (ibutamoren) is an oral growth hormone stimulating therapy for the treatment of pediatric growth hormone deficiency (PGHD), turner syndrome, children born small for gestational age (SGA), and other rare endocrine disorders. Lumos Pharma is headquartered in Austin, Texas, the US.

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.